Cost Effectiveness of Pembrolizumab and Ipilimumab in Advanced Melanoma
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1585
https://www.valueinhealthjournal.com/article/S1098-3015(16)01653-3/fulltext
Title :
Cost Effectiveness of Pembrolizumab and Ipilimumab in Advanced Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01653-3&doi=10.1016/j.jval.2016.03.1585
First page :
A149
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
301